Home / Science / Biology / Geology / Breakthrough: The Quest for Life-Changing Medicines

Breakthrough: The Quest for Life-Changing Medicines

AUTHOR
Price
€31.40
€34.90 -10%
Upon request
Dispatched within 15 - 25 days.

Add to wishlist

Meet the doctors, scientists, patients and campaigners tackling the world’s worst diseases

 

We often hear about the dark side of the pharmaceutical industry – from extortionate pricing to the opioid epidemic. But there’s another story to be told.

 

Through the story of eight revolutionary treatments, Dr William Pao cuts to the innovative heart of medical science and celebrates the tireless work of those fighting for better care. Behind each of these medicines – whether a potentially life-saving new treatment for cancer, or something as commonplace as paracetamol – there stands a cast of characters and a wealth of stories.

 

The trajectory from the laboratory to the local chemist is rarely a straight line. Eureka moments are few are far between. Drug hunting demands leaps of imagination and lateral thinking, the accumulation of the knowledge and expertise of many, and – nearly always – a hefty dollop of luck.

 

Breakthrough documents these journeys and grants a privileged look at the stories behind the medicines that improve – and very often save – our lives.

Author: Pao William
Publisher: ONEWORLD PUBLICATIONS
Pages: 352
ISBN: 9780861547340
Cover: Hardback
Edition Number: 1
Release Year: 2024

William Pao is a physician-scientist whose career has spanned academia, industry and biotech. He started his career as a thoracic oncologist, lab researcher and clinical investigator at Memorial Sloan-Kettering Cancer Center in New York and then Vanderbilt University in Nashville, where he also served as the Division Chief of Haematology/Oncology. Through executive leadership positions at Roche and Pfizer, he oversaw the discovery and development of portfolios of new molecular entities, many of which have been approved, to treat a variety of diseases. He currently is CEO and Co-Founder of a cancer biotechnology company.

You may also like

You have recently viewed

Newsletter

Subscribe to the newsletter to be the first to receive our new releases and offers
Your account Your wishlist